Reply to: On the pathophysiology of takotsubo syndrome triggered by administered adrenergic agonists, noted in the JADER database

J Cardiol. 2022 Apr;79(4):564-565. doi: 10.1016/j.jjcc.2021.11.005. Epub 2021 Nov 21.

Authors

Kenichiro Sato¹, Atsushi Iwata², Masanori Kurihara³, Tatsuo Mano¹, Tatsushi Toda¹

Affiliations

¹ Department of Neurology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
² Department of Neurology, Tokyo Metropolitan Geriatric Medical Center Hospital, Tokyo, Japan. Electronic address: iwata-tky@umin.ac.jp.
³ Department of Neurology, Tokyo Metropolitan Geriatric Medical Center Hospital, Tokyo, Japan.

PMID: 34815136
DOI: 10.1016/j.jjcc.2021.11.005

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenergic Agonists
Databases, Factual
Humans
Takotsubo Cardiomyopathy* / chemically induced
Takotsubo Cardiomyopathy* / physiopathology

Substances

Adrenergic Agonists